Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-14 · accession 0001567619-21-013923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-23 | 2021-07-21 | ANGO | Centea Scott | SVP, GM, VIT | A - Grant | $0.00 | +2,842 | 46.7K | +6% | $0 |
| DM | 2021-07-23 | 2021-07-14+ | ANGO | Centea Scott | SVP, GM, VIT | F - Tax | $25.47 | -1,183 | 44.2K | -3% | -$30.1K |
| DM | 2021-07-23 | 2021-07-21 | ANGO | Centea Scott | SVP, GM, VIT | A - Grant | $0.00 | +13.4K | 5,684 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | A | A | 2,842 | $0.00 | 46,663 | D | — | — | (F4) The acquisition of 2,842 shares of Common Stock of the Company represents 2,842 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025. |
| 2 | Common | Common Stock | 2021-07-18 | F | D | 344 | $24.76 | 43,821 | D | — | — | (F3) The exempt disposition of 344 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018. |
| 3 | Common | Common Stock | 2021-07-14 | F | D | 500 | $26.43 | 44,504 | D | — | — | (F1) The exempt disposition of 500 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020. |
| 4 | Common | Common Stock | 2021-07-17 | F | D | 339 | $24.76 | 44,165 | D | — | — | (F2) The exempt disposition of 339 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-21 | A | A | 7,721 | $0.00 | 7,721 | D | $10.27 · 2022-07-21 to 2031-07-21 | 7,721 Common Stock | (F6) These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025. |
| 6 | Derivative | Performance Right | 2021-07-21 | A | A | 5,684 | $0.00 | 5,684 | D | — · — to — | 5,684 Common Stock | (F5) Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. |